These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31759380)

  • 21. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
    Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
    Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma.
    Ben-Haj-Ayed A; Moussa A; Ghedira R; Gabbouj S; Miled S; Bouzid N; Tebra-Mrad S; Bouaouina N; Chouchane L; Zakhama A; Hassen E
    Immunol Lett; 2016 Jan; 169():23-32. PubMed ID: 26608400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of indoleamine 2,3-dioxygenase expression in patients with breast cancer].
    Sakurai K; Amano S; Enomoto K; Kashio M; Saito Y; Sakamoto A; Matsuo S; Suzuki M; Kitajima A; Hirano T; Negishi N
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1546-9. PubMed ID: 16315864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.
    Jacquemier J; Bertucci F; Finetti P; Esterni B; Charafe-Jauffret E; Thibult ML; Houvenaeghel G; Van den Eynde B; Birnbaum D; Olive D; Xerri L
    Int J Cancer; 2012 Jan; 130(1):96-104. PubMed ID: 21328335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FoxP3 and IDO in Canine Melanocytic Tumors.
    Porcellato I; Brachelente C; De Paolis L; Menchetti L; Silvestri S; Sforna M; Vichi G; Iussich S; Mechelli L
    Vet Pathol; 2019 Mar; 56(2):189-199. PubMed ID: 30381008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.
    Chung YR; Kim HJ; Jang MH; Park SY
    Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival.
    Ino K; Yamamoto E; Shibata K; Kajiyama H; Yoshida N; Terauchi M; Nawa A; Nagasaka T; Takikawa O; Kikkawa F
    Clin Cancer Res; 2008 Apr; 14(8):2310-7. PubMed ID: 18413819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ganoderic acid Me induces the apoptosis of competent T cells and increases the proportion of Treg cells through enhancing the expression and activation of indoleamine 2,3-dioxygenase in mouse lewis lung cancer cells.
    Que Z; Zou F; Zhang A; Zheng Y; Bi L; Zhong J; Tian J; Liu J
    Int Immunopharmacol; 2014 Nov; 23(1):192-204. PubMed ID: 25138378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma.
    Inaba T; Ino K; Kajiyama H; Yamamoto E; Shibata K; Nawa A; Nagasaka T; Akimoto H; Takikawa O; Kikkawa F
    Gynecol Oncol; 2009 Nov; 115(2):185-92. PubMed ID: 19665763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FoxP3, CTLA-4, and IDO in Canine Melanocytic Tumors.
    Porcellato I; Brachelente C; Cappelli K; Menchetti L; Silvestri S; Sforna M; Mecocci S; Iussich S; Leonardi L; Mechelli L
    Vet Pathol; 2021 Jan; 58(1):42-52. PubMed ID: 33021155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin D2 is a novel repressor of IFNγ induced indoleamine-2,3-dioxygenase via the DP1 receptor and cAMP pathway.
    Bassal NK; Hughes BP; Costabile M
    Prostaglandins Leukot Essent Fatty Acids; 2016 Jul; 110():48-54. PubMed ID: 26995677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PCC0208009 enhances the anti-tumor effects of temozolomide through direct inhibition and transcriptional regulation of indoleamine 2,3-dioxygenase in glioma models.
    Sun S; Du G; Xue J; Ma J; Ge M; Wang H; Tian J
    Int J Immunopathol Pharmacol; 2018; 32():2058738418787991. PubMed ID: 29993291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
    Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
    Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
    Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
    Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative Multiplexed Analysis of Indoleamine 2,3-Dioxygenase (IDO) and Arginase-1 (ARG1) Expression and Myeloid Cell Infiltration in Colorectal Cancer.
    Elomaa H; Härkönen J; Väyrynen SA; Ahtiainen M; Ogino S; Nowak JA; Lau MC; Helminen O; Wirta EV; Seppälä TT; Böhm J; Mecklin JP; Kuopio T; Väyrynen JP
    Mod Pathol; 2024 Apr; 37(4):100450. PubMed ID: 38369188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14.
    Chapman JA; Sgroi DC; Goss PE; Zarella E; Binns S; Zhang Y; Schnabel CA; Erlander MG; Pritchard KI; Han L; Badovinac-Crnjevic T; Shepherd LE; Pollak MN
    Breast Cancer Res Treat; 2016 May; 157(1):101-8. PubMed ID: 27116182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence.
    Ricciuti B; Leonardi GC; Puccetti P; Fallarino F; Bianconi V; Sahebkar A; Baglivo S; Chiari R; Pirro M
    Pharmacol Ther; 2019 Apr; 196():105-116. PubMed ID: 30521884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-Associated Fibroblasts and Microvessels Contribute to the Expression of Immunosuppressive Factor Indoleamine 2, 3-Dioxygenase in Human Esophageal Cancers.
    Cui G; Li C; Xu G; Sun Z; Zhu L; Li Z; Zheng W; Li J; Yuan A
    Pathol Oncol Res; 2018 Apr; 24(2):269-275. PubMed ID: 28470572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis.
    Isla Larrain MT; Rabassa ME; Lacunza E; Barbera A; Cretón A; Segal-Eiras A; Croce MV
    Tumour Biol; 2014 Jul; 35(7):6511-9. PubMed ID: 24687552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
    Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
    Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.